Obesity-related hypertension: Is there a role for selective leptin resistance?

Current Hypertension Reports

Volumn 6, Issue 3, 2004, Pages 230-235

  Correia, Marcelo L G ^a   Haynes, William G ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; EVIDENCE BASED MEDICINE; HORMONE BLOOD LEVEL; HORMONE METABOLISM; HORMONE RESISTANCE; HORMONE RESPONSE; HUMAN; HYPERTENSION; IN VITRO STUDY; MEDICAL RESEARCH; NERVE CELL NETWORK; NONHUMAN; OBESITY; PATHOGENESIS; REVIEW; SIGNAL TRANSDUCTION; SYMPATHETIC TONE; THEORETICAL MODEL; BLOOD PRESSURE; DRUG EFFECT; DRUG RESISTANCE; NERVE TRACT; PATHOPHYSIOLOGY; PHYSIOLOGY; UNITED STATES;

BLOOD PRESSURE; DRUG RESISTANCE; HUMANS; HYPERTENSION; LEPTIN; NERVE NET; NEURAL PATHWAYS; OBESITY; UNITED STATES;

EID: 4644340686     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-004-0074-9     Document Type: Review

References (42)

1. Collins S, Kuhn CM, Petro AE, et al.: Role of leptin in fat regulation. Nature 1996, 380: 677.
2. Haynes WG, Morgan DA, Walsh SA, et al.: Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997, 100: 270-278.
3. Dunbar JC, Hu Y, Lu H: Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 1997, 46: 2040-2043.
4. Halaas JL, Gajiwala KS, Maffei M, et al.: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995, 269: 543-546.
5. Shek EW, Brands MW, Hall JE: Chronic leptin infusion increases arterial pressure. Hypertension 1998, 31: 409-414.
6. Correia ML, Morgan DA, Sivitz WI, et al.: Leptin acts in the central nervous system to produce dose-dependent changes in arterial pressure. Hypertension 2001, 37: 936-942.
7. Carlyle M, Jones OB, Kuo JJ, Hall JE: Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension 2002, 39: 496-501.
8. Aizawa-Abe M, Ogawa Y, Masuzaki H, et al.: Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest 2000, 105: 1243-1252.
9. Mark AL, Shaffer RA, Correia ML, et al.: Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. J Hypertens 1999, 17: 1949-1953.
10. Frederich RC, Hamann A, Anderson S, et al.: Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1995, 1: 1311-1314.
11. Akira S: Functional roles of STAT family proteins: lessons from knockout mice. Stem Cells 1999, 17: 138-146.
12. Bjorbaek C, El-Haschimi K, Frantz JD, Flier JS: The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem 1999, 274: 30059-30065.
13. Bjorbaek C, Elmquist JK, Frantz JD, et al.: Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1998, 1: 619-625.
14. Banks WA, DiPalma CR, Farrell CL: Impaired transport of leptin across the blood-brain barrier in obesity. Peptides 1999, 20: 1341-1345.
15. El-Haschimi K, Pierroz DD, Hileman SM, et al.: Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 2000, 105: 1827-1832.
16. Correia ML, Haynes WG, Rahmouni K, et al.: The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes 2002, 51: 439-442.
17. Rahmouni K, Haynes WG, Morgan DA, Mark AL: Selective resistance to central neural administration of leptin in agouti obese mice. Hypertension 2002, 39: 486-490.
18. Zhou YT, Shimabukuro M, Lee Y, et al.: Enhanced de novo lipogenesis in the leptin-unresponsive pancreatic islets of prediabetic Zucker diabetic fatty rats: role in the pathogenesis of lipotoxic diabetes. Diabetes 1998, 47: 1904-1908.
19. Unger RG: Minireview: weapons of lean body mass destruction: The role of ectopic lipids in metabolic syndrome. Endocrinology 2003, 144: 5159-5165.
20. Shimabukuro M, Higa M, Zhou YT, et al.: Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats: role of serine palmitoyl-transferase overexpression. J Biol Chem 1998, 273: 32487-3290.
21. Zhou YT, Grayburn P, Karim A, et al.: Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci 2000, 97: 1784-1789.
22. Wang ZW, Pan WT, Lee Y, et al.: The role of leptin resistance in the lipid abnormalities of aging. FASEB J 2001, 15: 108-114.
23. Caro JF, Kolaczynski JW, Nyce MR, et al.: Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996, 348: 159-161.
24. Considine RV, Considine EL, Williams CJ, et al.: The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations. Diabetes 1996, 45: 992-994.
25. Steinberg GR, Parolin ML, Heigenhauser GJ, Dyck DJ: Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am J Physiol Endocrinol Metab 2002, 283: E187-E192.
26. Halaas JL, Boozer C, Blair-West J, et al.: Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci 1997, 94: 8878-8883.
27. Morgan DA, Rahmouni K, Mark AL, et al.: Selective leptin resistance during high fat diet in mice: preservation sympathetic activation despite attenuation of metabolic responses [abstract]. Hypertension 2001, 38: 34.
28. Rahmouni K, Morgan DA, Morgan GM, et al.: Renal-specific preservation of sympathoexcitatory effect of leptin in diet-induced obese mice [abstract]. Hypertension 2003, 42: 421.
29. Haynes WG, Morgan DA, Djalali A, et al.: Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension 1999, 33: 542-547.
30. Correia ML, Morgan DA, Mitchell JL, et al.: Role of corticotrophin-releasing factor in effects of leptin on sympathetic nerve activity and arterial pressure. Hypertension 2001, 38: 384-388.
31. Hausberg M, Morgan DA, Chapleau MA, et al.: Differential modulation of leptin-induced sympathoexcitation by baroreflex activation. J Hypertens 2002, 20: 1633-1641.
32. Marsh AJ, Fontes MA, Killinger S, et al.: Cardiovascular responses evoked by leptin acting on neurons in the ventro-medial and dorsomedial hypothalamus. Hypertension 2003, 42: 488-493.
33. Rahmouni K, Haynes WG, Morgan DA, Mark AL: Intracellular mechanisms involved in leptin regulation of sympathetic outflow. Hypertension 2003, 41: 763-767.
34. Niswender KD, Schwartz MW: Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities. Front Neuroendocrinol 2003, 24: 1-10.
35. Grassi G, Seravalle G, Cattaneo BM, et al.: Sympathetic activation in obese normotensive subjects. Hypertension 1995, 25: 560-563.
36. Agata J, Masuda A, Takada M, et al.: High plasma immunoreactive leptin level in essential hypertension. Am J Hypertens 1997, 10: 1171-1174.
37. Matsubara M, Chiba H, Maruoka S, Katayose S: Elevated serum leptin concentrations in women with components of multiple risk factor clustering syndrome. J Atheroscler Thromb 2000, 7: 231-237.
38. Barba G, Russo O, Siani A, et al.: Plasma leptin and blood pressure in men: graded association independent of body mass and fat pattern. Obes Res 2003, 11: 160-166.
39. Eikelis N, Schlaich M, Aggarwal A, et al.: Interactions between leptin and the human sympathetic nervous system. Hypertension 2003, 41: 1072-1079.
40. Paolisso G, Manzella D, Montano N, et al.: Plasma leptin concentrations and cardiac autonomic nervous system in healthy subjects with different body weights. J Clin Endocrinol Metab 2000, 85: 1810-1814.
41. Snitker S, Pratley RE, Nicolson M, et al.: Relationship between muscle sympathetic nerve activity and plasma leptin concentration. Obes Res 1997, 5: 338-340.
42. Narkiewicz K, Kato M, Phillips BG, et al.: Leptin interacts with heart rate but not sympathetic nerve traffic in healthy male subjects. J Hypertens 2001, 19: 1089-1094.